VICAL LX01-315 : Essai de phase 3 comparant l'efficacité et la tolérance d'un traitement par injections intralésionelles d'Allovectin-7® à la darcarbazine ou au témozolomide, chez des patients ayant un mélanome métastatique en rechute. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] A phase 3 clinical trial to evaluate the safety and efficacy of treatment with 2 mg intralesional Allovectin-7® compared to dacarbazine (DTIC) or temozolomide (TMZ) in subjects with recurrent metastat...

• Country France
• organs Mélanomes cutanés
• Specialty Autres (cryothérapie, radiofréquence, homéopathie,...)

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7® Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects with Recurrent Metastatic Melanoma To compare the efficacy and safety of treatment with Allovectin-7® versus treatment with DTIC or TMZ in subjects with recurrent metastatic melanoma.

• Country None
• organs None
• Specialty None